<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03107650</url>
  </required_header>
  <id_info>
    <org_study_id>0485762</org_study_id>
    <nct_id>NCT03107650</nct_id>
  </id_info>
  <brief_title>Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer</brief_title>
  <acronym>PREMARE</acronym>
  <official_title>Preoperative Prediction Model of Pathological Outcomes (Mesorectum Quality and Positive Circumferential Resection Margin) in Patients With Mid-low Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pere Planellas Giné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elaboration of a preoperative prediction model of the quality of the mesorectum and the
      involvement of the circumferential margin in patients with mid-low rectal cancer who undergo
      laparoscopic anterior rectal resection.

      In a second phase the investigators will study the utility of the prediction model in
      classifying patients with high risk of suboptimal quality of mesorectum and/or positive
      circumferential margin. Patients with high preoperative risk will undergo a transanal total
      mesorectal excision and patients with low risk a laparoscopic transabdominal mesorectal
      excision. The investigators finally will compare pathological outcomes ( quality of
      mesorectum and circumferential margin), survival and recurrence between the two groups.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2018</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the quality of mesorectum in the rectal specimen according to international consensus (goog quality, moderate quality and poor quality)</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluation of the quality of mesorectum as optimal or suboptimal (international consensus defines three grades of resection:
Group 1: including mesorectal resection, good quality Group 2: intramesorectal resection: moderate quality Group 3: resection in the muscularis propria, poor quality).
Investigators will group patients into two groups: optimal mesorectum (group 1) and suboptimal mesorectum (group 2-3).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of the circumferential margin status in the rectal specimen according international consensus (positive margin if tumor ≤ 1mm from circumferential margin)</measure>
    <time_frame>30 days</time_frame>
    <description>Evaluation of the circumferential margin status (positive or negative) in the rectal specimen according international consensus (positive margin if tumor ≤ 1mm from circumferential margin)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence</measure>
    <time_frame>2 years</time_frame>
    <description>Rate of tumor recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>2 years</time_frame>
    <description>Rate of survival</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>High risk patients</arm_group_label>
    <description>Patients with high risk of suboptimal mesorectum quality and/or positive circumferential margin after the application of the preoperative prediction model developed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low risk patients</arm_group_label>
    <description>Patients with low risk of suboptimal mesorectum quality and/or positive circumferential margin after the application of the preoperative prediction model developed</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal total mesorectal excision of rectal cancer</intervention_name>
    <description>To perform a total mesorectal excision through a transanal approach</description>
    <arm_group_label>High risk patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected of mid-low rectal cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients directed to laparoscopic anterior rectal resection through a transabdominal
             or a transanal approach.

          -  Age ≥ 18 years

          -  Histology of adenocarcinoma or adenoma

          -  With or without neoadjuvant chemoradiotherapy

          -  TNM classification: T2 or T3, any N stage or M stage

          -  Intention of resection R0

        Exclusion Criteria:

          -  TNM classification: T1 or T4.

          -  Complicated rectal cancer or emergency surgery.

          -  Previous major colorectal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 11, 2017</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</investigator_affiliation>
    <investigator_full_name>Pere Planellas Giné</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

